This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Rohto Pharmaceutical Co., Ltd.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Xuan Trung Ngo: Innovator in Mesenchymal Stem Cell Research
Introduction
Xuan Trung Ngo is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of mesenchymal stem cell research, focusing on innovative methods for preparing and utilizing these cells in therapeutic applications. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Xuan Trung Ngo's latest patents include groundbreaking inventions related to ROR1-positive mesenchymal stem cells. His patents encompass a method for preparing these cells, a pharmaceutical composition containing them, and a method for preventing or treating diseases using ROR1-positive mesenchymal stem cells. The objective of these inventions is to provide novel mesenchymal stem cells that demonstrate superior therapeutic effects against various diseases. The ROR1-positive mesenchymal stem cells are characterized by their positivity for specific cell surface markers, including CD29, CD73, CD90, CD105, and CD166, and are derived from umbilical cord or adipose tissue.
Career Highlights
Xuan Trung Ngo is currently associated with Rohto Pharmaceutical Co., Ltd., where he continues to advance his research in stem cell technology. His work is instrumental in developing new therapeutic strategies that leverage the unique properties of mesenchymal stem cells.
Collaborations
Xuan Trung Ngo collaborates with esteemed colleagues, including Eiko Uno and Masayo Yumoto, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the field of regenerative medicine.
Conclusion
Xuan Trung Ngo's innovative research in mesenchymal stem cells represents a significant advancement in therapeutic applications. His contributions are expected to lead to improved treatment options for various diseases, showcasing the importance of continued innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile